PubMed COVID-19 Clinical Care

CONCLUSION: Patients with non-severe COVID-19 and psychiatric disorders usually have a good prognosis and do not require long-term antipsychotic medication. Patients with uncontrollable mental symptoms experienced rapid remission after immunotherapy

CONCLUSION: The interplay between slow vaccination and low GDP per capita drives high mortality.

Environmental hazards and/or pandemics may push humans to use different protective methods to maintain their well-being. This study aimed to identify populations vulnerable to psychometric challenges and fatigue during the Coronavirus Disease (COVID

INTRODUCTION: Mucormycosis has emerged as one of the most fatal complications arising due to COVID-19, though it has to be mentioned that the disease is capable of causing serious illness even on its own.

CONCLUSION: SAB remains a challenging infection that is amplified by the pandemic. Older age and ICU admission are significant mortality predictors. In settings with a high prevalence of MRSA, factors like age, sex, and quality of care outweigh

Efficient recruitment of eligible participants is a significant challenge for clinical research studies. This challenge was exacerbated during the COVID-19 pandemic when in-person recruitment was not an option. In 2020, the University of Minnesota

[This corrects the article DOI: 10.1016/j.ijregi.2021.10.008.].

[This corrects the article DOI: 10.1016/j.ijregi.2021.10.008.].

CONCLUSIONS: Findings demonstrate the underlying importance of judgment variables for vaccine choices and uptake, suggesting that vaccine education and messaging might target varying judgment profiles to improve uptake. These methods could also be

While industry and regulators' interest in decentralized clinical trials (DCTs) is long-standing, the Covid-19 pandemic accelerated and broadened the adoption and experience with these trials. The key idea in decentralization is bringing the clinical